The Society for Clinical Research Sites (SCRS), a global trade organization fully dedicated to representing the interests of clinical research sites, has announced an expanded relationship with inVentiv Health, a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of much-needed therapies to market.
As a Site Engagement Partner, inVentiv Health will continue to participate on the SCRS Global Impact Board, which works closely with SCRS' Leadership Council to provide advice on strategic initiatives for SCRS.
In addition, inVentiv Health will host two Site Advocacy Groups (SAGs) to gain access to the expertise and insights of SCRS members who have deep knowledge of operational and clinical hurdles that can impact trial conduct.
"Investigational sites play an essential role in conducting successful clinical trials," said Susan Stansfield, Ph.D., executive vice president, Clinical Division, inVentiv Health. "Through this expanded partnership, we will work together with sites to design enhanced processes and procedures to accelerate clinical trial effectiveness."
"inVentiv Health's increased commitment to site collaboration with SCRS as a Site Engagement Partner is even more exciting because of their involvement through two SAGs," said Christine Pierre, president of SCRS. "Continued growth in the SAG program and other multi-stakeholders programs affirms that inVentiv Health see SCRS' commitment to site sustainability as essential to their own sustainability."